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Activation of the tcpPH promoter on the Vibrio pathogenicity island by AphA and AphB initiates the Vibrio
cholerae virulence cascade and is regulated by quorum sensing through the repressive action of HapR on aphA
expression. To further understand how the chromosomally encoded AphA protein activates tcpPH expression,
site-directed mutagenesis was used to identify the base pairs critical for AphA binding and transcriptional
activation. This analysis revealed a region of partial dyad symmetry, TATGCA-N6-TNCNNA, that is important
for both of these activities. Searching the V. cholerae genome for this binding site permitted the identification
of a second one upstream of a penicillin V amidase (PVA) gene on the small chromosome. AphA binds to and
footprints this site, which overlaps the pva transcriptional start, consistent with its role as a repressor at this
promoter. Since aphA expression is under quorum-sensing control, the response regulators LuxO and HapR
also influence pva expression. Thus, pva is repressed at low cell density when AphA levels are high, and it is
derepressed at high cell density when AphA levels are reduced. Penicillin amidases are thought to function as
scavengers for phenylacetylated compounds in the nonparasitic environment. That AphA oppositely regulates
the expression of pva from that of virulence, together with the observation that PVA does not play a role in
virulence, suggests that these activities are coordinated to serve V. cholerae in different biological niches.
involvement in toxT activation they also play an important role
in regulating the expression of the outer-membrane proteins
OmpU and OmpT (7, 25, 26, 32).
The activation of the tcpPH operon on the VPI initiates the
virulence cascade through the cooperation of two unlinked
regulators located on the large chromosome, AphA and AphB
(19, 41). AphA is a member of a small family of regulators that
show homology to PadR, a repressor that controls the detoxification of phenolic acids (1), and AphB is a LysR-type regulator (19, 22). The specific roles of these proteins in V. cholerae
aside from virulence gene regulation are not yet known.
Stimuli within the host environment typically serve as signals
to allow pathogenic bacteria to mount a productive infection
when they are in an appropriate biological niche. In V. cholerae, several chromosomally located genes that normally function to sense and regulate gene expression in response to
environmental cues influence the expression of the virulence
cascade. For example, H-NS, CRP, and PepA are transcriptional regulators that influence expression from various promoters within the cascade in response to factors such as temperature and pH (2, 35, 40). In addition, in certain strains of V.
cholerae the virulence cascade is also responsive to cell density
(47). Three quorum-sensing systems apparently function in
parallel to control the expression of the cascade through the
activity of the response regulator LuxO (30). At low cell density, LuxO functions to activate a putative repressor protein
that reduces the expression of the V. cholerae LuxR homolog
HapR, thus permitting high-level expression of the cascade. At
high cell densities, LuxO fails to activate the putative repressor
protein resulting in derepression of hapR, and HapR in turn
shuts off the virulence cascade by binding to a site in the aphA
promoter and repressing its expression (23). The regulation of
aphA expression by HapR thus serves to link quorum sensing

A fascinating interplay exists between the virulence genes
acquired by V. cholerae through horizontal gene transfer events
and the ancestral chromosomal genes recruited to regulate
them. This interplay serves to link virulence to the physiology
of the cell, thereby maximizing the ability of the organism to
cause disease when it is in an appropriate environmental niche
and to conserve these resources when it is not. The acquisition
of two pathogenicity elements into the large chromosome of V.
cholerae, the Vibrio pathogenicity island (VPI) (16, 17) and the
lysogenic CTX phage (45), conferred upon the organism the
ability to cause the life-threatening diarrheal disease cholera.
The VPI carries the genes required for the synthesis and assembly of the toxin-coregulated pilus (TCP) (43), the primary
colonization factor, and CTX encodes cholera toxin (CT), a
potent ADP-ribosylating toxin (15).
Once in the epithelium of the upper small intestine, a complex network comprised of regulators carried both within the
VPI and the V. cholerae ancestral genome coordinates the
expression of the TCP and CT genes. ToxT is an AraC-type
regulator encoded by the VPI that directly activates the expression of tcp and ctx as well as other genes (4, 8, 13, 46). The
activation of toxT expression is unusual in that it requires
cooperation between two homologous pairs of transmembrane
transcriptional activators, TcpP/TcpH and ToxR/ToxS (24).
TcpP and TcpH (3, 12) are encoded by an operon within the
VPI and have no known functions other than their role in toxT
activation. ToxR and ToxS (31, 33) are encoded by a separate
operon on the large chromosome, and in addition to their
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in V. cholerae to pathogenesis. However, not all virulent strains
of V. cholerae have a fully functional quorum-sensing system
that regulates virulence gene expression. Certain strains, such
as El Tor N16961 and classical O395, possess a naturally occurring frameshift mutation in hapR (47), and other strains,
such as classical CA401, have a naturally occurring point mutation in the aphA promoter that prevents HapR from binding
even if it is functional (23).
AphA has previously been shown to bind to a region of the
tcpPH promoter between ⫺101 and ⫺71 from the start of
transcription (21). AphA appears to activate transcription by
enhancing the ability of AphB to bind to its recognition site, a
region of interrupted dyad symmetry from ⫺69 to ⫺53 that
displays the LysR recognition motif (21, 22). It is the ability of
AphB to bind to this motif, which differs by a single base pair
in the classical and El Tor biotypes, that determines the biotype specificity of virulence gene expression in V. cholerae (20,
22). To gain further insights into how AphA contributes to the
activation of the tcpPH promoter, a systematic mutational
analysis of the AphA binding site from positions ⫺75 to ⫺98
was carried out. As shown here, this analysis identified nine
base pairs absolutely critical for AphA to bind to the tcpPH
promoter and activate transcription in the presence of AphB.
These nine base pairs lie within a region of partial dyad symmetry that has the sequence TATGCA-N6-TNCNNA. Since
aphA is located in the ancestral genome and its only known
target, the tcpPH promoter, is present on an acquired pathogenicity element, it seemed likely that AphA might regulate
the expression of other genes in V. cholerae and also link them
to quorum sensing and pathogenesis by binding to a similar
site. Searching the V. cholerae genome for matches to the 18-bp
AphA binding site led to the identification of a gene on the
small chromosome encoding a penicillin V amidase (PVA)
that is regulated by AphA.
Penicillin amidases have been identified in a wide variety of
different microorganisms, such as bacteria, yeast, and filamentous fungi (for a review see reference 44). These enzymes have
had a significant impact on human health over the last 30 years
because of their important role in the production of useful
␤-lactam antibiotics to aid in the control of infectious bacterial
diseases. By hydrolyzing penicillins to yield 6-aminopenicillanic acid (6-APA), these enzymes simplified the procedure for
generating a key intermediate that is used in the production of
semisynthetic derivatives with a wide range of antimicrobial
activities. Penicillin amidases have been classified based on
their various substrate specificities. For example, the preferred
substrate for type I enzymes is phenoxymethylpenicillin (penicillin V), for type II enzymes it is benzylpenicillin (penicillin
G), and for type III enzymes (D-␣-aminobenzylpenicillin) it is
ampicillin. Although their physiological role is still not clear, it
is thought that they serve as scavengers for phenylacetylated
compounds in carbon-limiting environments (44).
We show here that AphA negatively regulates PVA gene
expression in both the classical and El Tor biotypes of V.
cholerae by binding to a site virtually identical to that at the
tcpPH promoter which overlaps the pva transcriptional start
site. In El Tor strain C6706, the pva gene is also regulated by
quorum sensing such that its expression is reduced at low cell
density when AphA levels are high and its expression increases
at higher cell density when aphA is repressed by HapR. Since
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PVA does not appear to play a role in virulence, the ability of
AphA to oppositely regulate pva expression from that of virulence gene expression may provide V. cholerae with advantages in different environmental niches.
MATERIALS AND METHODS
Bacterial strains and expression plasmids. The V. cholerae strains and expression plasmids used in this study are listed in Table 1. Strains were maintained at
⫺70°C in Luria-Bertani (LB) medium (28) containing 30% (vol/vol) glycerol.
Antibiotics were used at the following concentrations in LB medium: ampicillin,
100 g/ml; kanamycin, 45 g/ml; polymyxin B, 50 U/ml; streptomycin, 1 mg/ml.
5-Bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) was used in LB agar
at 40 g/ml.
Construction of V. cholerae ⌬pva-lacZ chromosomal fusion. The V. cholerae
⌬pva plasmid pGKK264 was constructed by amplifying two DNA fragments from
C6706 with primer pair HydB (5⬘-GATCGGGATCCATGCAGGGATCGCAA
TGGGC) and Hyd2 (5⬘-GATCGGCGGCCGCGTGTTTCATCTTCATCT
CTG) and primer pair HydN (5⬘-GATCGGCGGCCGCAGCAGAATGATCA
GGATATTG) and HydE (5⬘-GATCGGAATTCTTTCTAATGTCTAATCA
TGC) and ligating them into pKAS154 (23). The ⌬pva-lacZ fusion plasmid was
constructed by inserting a promoterless lacZ gene between the two fragments in
pGKK264, generating pGKK265. The resulting fusion was introduced into
KSK262 and its ⌬aphA derivative KSK1863 by allelic exchange.
Construction of V. cholerae chromosomal deletions. The construction of the
classical biotype ⌬aphA plasmid pKAS98 was previously described (41). The El
Tor biotype ⌬aphA plasmid pGKK259 was constructed by amplifying two products from C6706 with primer pair YF13 (23) and YF29 (5⬘-GATCGGCGGCC
GCGATAACGTGTGGTAATGACATG) and primer pair YF4 and YF6 (41).
These fragments were ligated into pKAS154. The construction of the ⌬luxO
plasmid pGKK249 and the ⌬hapR plasmid pKAS187 was previously described
(23). The mutations were introduced into V. cholerae by allelic exchange.
Introduction of AphA binding site changes into the tcpPH promoter. The
AphA binding site mutations were constructed by amplifying fragments from the
classical biotype by using overlapping primers containing the site for the type IIS
restriction enzyme EarI (see Fig. 1). For each substitution (positions ⫺75 to
⫺98), fragments were generated by amplification with a specific mutant primer
(Table 2) and I-Eco2 (20). These fragments were then ligated into pKAS32 (39)
together with fragments generated by using overlapping wild-type primers and
TP-Bam (41). The overlapping primer for mutants ⫺75 to ⫺82 was EarC3, for
mutants ⫺83 to ⫺88 it was EarC12, for mutants ⫺89 to ⫺94 it was EarC13, and
for mutants ⫺95 to ⫺98 it was EarC14. The mutations were introduced into the
V. cholerae strain GK300 from the resulting plasmids (see Table 2) and were
confirmed by sequencing.
Construction of the pva expression plasmid. The pva expression plasmid
pGKK268 was constructed by amplifying the pva coding region from C6706 with
primers Hyd1 (5⬘-TAATCACTTTATTTCCATGG) and HydS (5⬘-GATCGGT
CGACTATTAGTCACCGCAATATCC), digesting the resulting product with
EcoRI and SalI, and ligating the resulting product into pMMB66EH (10).
Identification of the pva transcriptional start site. Total RNA was isolated
from C6706 after growth for 3.5 h under AKI conditions (14) by using RNA-WIZ
(Ambion). The RNA was subjected to 5⬘ rapid amplification of cDNA ends
(RACE) (Gibco BRL) as described previously (20), except that first-strand
cDNA synthesis was carried out by using the pva-specific primer HydR1 (5⬘-C
GTAGTTATCGAGAAAATAC), and the first and second nested primers were
HydR2 (5⬘-GCCCAAGCACCAGCGGTCAG) and HydR3 (5⬘-AGGCTTTCC
TGCCTTGGTTG).
Purification of AphA. To obtain a purity of AphA greater than what was
previously obtained (21), the IMPACT-CN protein fusion and purification system (New England Biolabs) was used. Amplification of the aphA gene from
classical strain O395 was carried out with YF30 (GATCGCATATGTCATTAC
CACACGTTATC) and YF31 (GATCGGCTCTTCAGCATGCCATCGCGTT
CAATTCTGC). After digestion of the fragment with NdeI and SapI, it was
ligated into pTXB-1. The resulting plasmid, pWEL18, was introduced into Escherichia coli strain ER2566 and grown overnight in LB with ampicillin at 37°C.
Cells were collected by centrifugation and were resuspended in column buffer
(20 mM Tris [pH 8.0], 500 mM NaCl, 1 mM EDTA). The extract was sonicated
and clarified by centrifugation at 14,000 rpm for 30 min in an SS34 rotor. The
supernatant was then loaded onto a chitin column equilibrated with column
buffer and was washed with 10 volumes of column buffer and high-salt column
buffer (20 mM Tris [pH 8.0], 1 M NaCl, 1 mM EDTA). The column was then
quickly washed with 3 volumes of cleavage buffer (column buffer containing 100
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TABLE 1. Bacterial strains and expression plasmids used in this study
Strain or plasmid

Relevant genotype or characteristics

V. cholerae
C6706 str2
KSK262
O395
KSK618
GK300
GK797
GK798
GK799
GK800
KSK1309
GK834
GK835
GK801
GK845
GK846
GK847
GK848
GK872
GK873
WL40
WL35
WL36
WL37
WL39
WL38
WL57
WL52
WL55
WL56
GK910
GK925
GK927
GK930
KSK1683
KSK1863
KSK1918
KSK1920

El Tor Inaba Smr
C6706 str2 ⌬lacZ3
classical Ogawa Smr
O395 ⌬lacZ tcpP-lacZ
KSK618 ⌬tcpPH promoter
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
GK300 ⫹ tcpPH promoter,
C6706 ⌬aphA
C6706 ⌬pva-lacZ
C6706 ⌬pva-lacZ ⌬aphA
C6706 ⌬pva
O395 ⌬lacZ ⌬aphA
KSK262 ⌬aphA
C6706 pva-lacZ ⌬hapR
C6706 pva-lacZ ⌬luxO

Expression plasmid
pGKK268

pMMB66EH pva

mM dithiothreitol [DTT]) and was left overnight at 16°C. AphA was then eluted
off the column by using column buffer without DTT. The resulting protein was
dialyzed overnight in a solution of 20 mM Tris (pH 7.5), 1 mM EDTA, 10 mM
NaCl, and 0.1 mM DTT, glycerol was added to 10%, and it was frozen at ⫺70°C.
The final purity was estimated to be greater than 98%.
Gel shift experiments. The 135-bp fragments from the tcpPH promoter were
amplified by PCR from O395 or from the mutant plasmids listed in Table 2 by
using TP-Eco5 (⫺175) (21) and TP-Bam5 (⫺40) (22). The 303- and 173-bp
fragments from the pva promoter were amplified from either C6706 or O395,

⫺75
⫺76
⫺77
⫺78
⫺79
⫺80
⫺81
⫺82
⫺83
⫺84
⫺85
⫺86
⫺87
⫺88
⫺89
⫺90
⫺91
⫺92
⫺93
⫺94
⫺95
⫺96
⫺97
⫺98

A to C
T to A
T to G
A to C
C to G
T to G
C to A
T to G
T to A
G to T
A to C
G to C
C to G
T to A
A to C
A to C
C to G
G to T
T to A
A to C
T to A
T to A
A to C
T to A

Reference or source

Laboratory collection
19
Laboratory collection
41
20
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work

respectively, by using Hyd2 (⫹191) together with Hyd1 (⫺113) or with Hyd3
(⫹18) (5⬘-TGTGTTGTATTTGAATTCTC). The fragments were gel purified
and 3⬘-end labeled with digoxigenin as previously described (21). Binding reactions with AphA were carried out as previously described (21).
DNaseI footprinting. A 233-bp fragment was PCR amplified from C6706 with
HydB3 (5⬘-GATCGGGATCCTAATCACTTTATTTCCATGG) (⫺113) and
HydV4 (5⬘-GATCGGATATCCCTATAGTCCTAACGTGAGG) (⫹120) and
was ligated into pBluescript (Stratagene), generating pWEL21. For upper-strand
labeling the inserts were excised with BamHI and HindIII. For lower-strand

FIG. 1. Schematic showing the positions of the primers used to introduce the AphA binding site changes into the tcpPH promoter. The base
pairs that were individually changed, from ⫺75 to ⫺98, are shown in bold. wt, wild type.
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TABLE 2. Primers used for mutational analysis of the AphA binding site in the tcpPH promotera
Primer

Sequence

Plasmid

EAR75C
EAR76A
EAR77G
EAR78C
EAR79G
EAR80G
EAR81A
EAR82G
EARC3
EAR83A
EAR84T
EAR85C
EAR86C
EAR87G
EAR88A
EARC12
EAR89C
EAR90C
EAR91G
EAR92T
EAR93A
EAR94C
EARC13
EAR95A
EAR96A
EAR97C
EAR98A
EaRC14

GATCGCTCTTCGTGAGAATGAGAACTCGATTG
GATCGCTCTTCGTGATTATGAGAACTCGATTG
GATCGCTCTTCGTGATACTGAGAACTCGATTG
GATCGCTCTTCGTGATAAGGAGAACTCGATTG
GATCGCTCTTCGTGATAATCAGAACTCGATTG
GATCGCTCTTCGTGATAATGCGAACTCGATTG
GATCGCTCTTCGTGATAATGATAACTCGATTG
GATCGCTCTTCGTGATAATGAGCACTCGATTG
GATCGCTCTTCGTCAACTGCAAAATTAGATTG
GATCGCTCTTCGAGATCTCGATTGCATAATATTTAAATTG
GATCGCTCTTCGAGAAATCGATTGCATAATATTTAAATTG
GATCGCTCTTCGAGAACGCGATTGCATAATATTTAAATTG
GATCGCTCTTCGAGAACTGGATTGCATAATATTTAAATTG
GATCGCTCTTCGAGAACTCCATTGCATAATATTTAAATTG
GATCGCTCTTCGAGAACTCGTTTGCATAATATTTAAATTG
GATCGCTCTTCGTCTCATTATCAACTGCAAAATTAG
GATCGCTCTTCGCGAGTGCATAATATTTAAATTGT
GATCGCTCTTCGCGATGGCATAATATTTAAATTGTT
GATCGCTCTTCGCGATTCCATAATATTTAAATTGTTA
GATCGCTCTTCGCGATTGAATAATATTTAAATTGTTAA
GATCGCTCTTCGCGATTGCTTAATATTTAAATTGTTAAA
GATCGCTCTTCGCGATTGCAGAATATTTAAATTGTTAAAA
GATCGCTCTTCGTCGAGTTCTCATTATCAACTG
GATCGCTCTTCGCATTATATTTAAATTGTTAAAAAA
GATCGCTCTTCGCATATTATTTAAATTGTTAAAAAAA
GATCGCTCTTCGCATAAGATTTAAATTGTTAAAAAAAA
GATCGCTCTTCGCATAATTTTTAAATTGTTAAAAAAAAT
GATCGCTCTTCGATGCAATCGAGTTCTCATTATC

pGKK208
pGKK209
pGKK211
pGKK212
pKAS168
pGKK237
pGKK238
pGKK210

a

pGKK243
pGKK244
pGKK245
pGKK246
pGKK247
pGKK248
pWEL9
pWEL4
pWEL5
pWEL6
pWEL8
pWEL7
pWEL15
pWEL19
pWEL16
pWEL17

Substitution mutations are shown in bold.

labeling the inserts were excised with XbaI and EcoRV. The fragments were gel
purified, treated with shrimp alkaline phosphatase, and kinased with [␥-33P]ATP
(3,000 Ci/mmol; NEN). Singly end-labeled fragments were obtained by digestion
with EcoRV (for the upper strand) and BamHI (for the lower strand). The
conditions for AphA binding were as previously described (21, 22).
Antibody production. AphA was purified as previously described (21) and was
electrophoresed on a 12.5% sodium dodecyl sulfate–polyacrylamide gel electrophoresis gel. AphA was excised from the gel and was electroeluted from the
acrylamide as previously described (11). Antibodies were generated at the Pocono Rabbit Farms by using established protocols. Nonspecific antibodies to
other V. cholerae proteins were removed by treatment of the antibody with an
acetone powder (11) prepared from the O395 ⌬aphA mutant strain KSK1683.
Immunoblot analysis. Extracts were prepared from cultures grown in AKI
conditions (14). The extracts were subjected to electrophoresis on a 12.5%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis gel, transferred to
nitrocellulose, probed with anti-AphA antibody, and visualized by using the ECL
(enhanced chemiluminescence) detection system (Amersham).
PVA assays. Cell extracts were prepared by growing the various strains in LB
at 37°C for 7 h. The cells were collected by centrifugation and were resuspended
in a 1/8 volume of buffer A (20 mM Na2HP04, 10 mM DTT, 1 mM EDTA [pH
7.0]). They were sonicated, spun in a microcentrifuge at 4°C for 30 min, and
dialyzed against buffer A. Measurements of total protein were made by using the
Bio-Rad Assay Reagent. Reaction mixtures contained 250 g of protein in 0.1 M
sodium citrate buffer, pH 5.8, with 2% potassium salt of penicillin V. Incubation
was at 37°C for 30 min, and 6-APA was measured spectrophotometrically as
previously described (18).
␤-Galactosidase assays. Assays with V. cholerae tcpP-lacZ fusions were carried
out (28) after 3.5 h of shaking at 30°C and with pva-lacZ fusions after 3.5 or 7.5 h
of growth under AKI conditions (14).
In vivo competition assays. The infant mouse competition assays were performed essentially as described previously (43). Suckling CD-1 mice (3 to 5 days
old; Charles River) were inoculated orally from cultures grown overnight in LB
(pH 6.5) at 30°C, and the total CFU were obtained from the small intestine of
four to six mice after 24 h by plating intestinal homogenates on streptomycin
X-Gal plates.

RESULTS
Mutational analysis of the binding site for AphA at the
tcpPH promoter. AphA cooperates with AphB to activate the
transcription of tcpPH and to initiate the expression of the
virulence cascade. To gain further insights into the mechanism
by which this process occurs, the region of the tcpPH promoter
previously shown to be footprinted by AphA (21) was systematically mutagenized to identify those base pairs important for
AphA binding and transcriptional activation. Substitution mutations were individually introduced into each position from
⫺98 to ⫺75 by incorporating each into a primer with an EarI
restriction site (see Fig. 1 and Table 2) and performing PCR
together with wild-type primers. After ligating the products
together to produce seamless junctions, the mutations were
introduced into a classical biotype tcpP-lacZ fusion strain by
allelic exchange. Out of the 24 positions that were analyzed, 9
were found to be critical for tcpPH expression in that they
reduced expression of the promoter to less than 35% (Fig. 2A).
In the upstream region, substitutions in a contiguous 6-bp
stretch from position ⫺95 to ⫺90 reduced tcpPH expression to
less than 30%. In the downstream region, only changes at
positions ⫺83, ⫺81, and ⫺78 showed a reduction to 34% or
lower. Position ⫺79 had an intermediate effect on transcription with a reduction of approximately 50%. The fact that the
sequence comprising the base pairs that are critical for AphA
to activate the expression of tcpPH (from ⫺95 to ⫺78) displays
partial dyad symmetry (TATGCA-N6-TNCNNA) suggests
that these base pairs serve as the binding site for AphA at the
tcpPH promoter.
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FIG. 2. Mutational analysis of the AphA binding site at the tcpPH promoter. (A) V. cholerae strains were grown in LB (pH 6.5) at 30°C. From
left to right: KSK618 (wild-type [wt] tcpP-lacZ); WL56 (⫺98A), WL55 (⫺97C), WL52 (⫺96A), WL57 (⫺95A), WL38 (⫺94C), WL39 (⫺93A),
WL37 (⫺92T), WL36 (⫺91G), WL35 (⫺90C), WL40 (⫺89C), GK873 (⫺88A), GK872 (⫺87G), GK848 (⫺86C), GK847 (⫺85C), GK846 (⫺84T),
GK845 (⫺83A), GK801 (⫺82G), GK835 (⫺81A), GK834 (⫺80G), KSK1309 (⫺79G), GK800 (⫺78C), GK799 (⫺77G), GK798 (⫺76A), and
GK797 (⫺75C). Positions reducing expression of the promoter to 34% or lower are shaded in gray, and the corresponding bases are in gray.
(B) AphA binding to various 135-bp mutant promoter fragments from ⫺175 to ⫺40. The first lane in each set has no protein added, and the second
lane has 5 ng (15 nM) of AphA added.

To determine whether the base pair alterations that decreased tcpPH expression above were due to a reduction in the
ability of AphA to bind to DNA, gel shift analysis was carried
out with promoter fragments carrying the substitution mutations that comprise the region of dyad symmetry (⫺95 to ⫺90
and ⫺83 to ⫺78). For these experiments, a preparation of
AphA was utilized that was of greater purity than that which
was previously achieved (21). This was accomplished by using
an intein-mediated purification system (IMPACT) in which a
self-cleaving intein and a chitin binding domain were fused to
the carboxy-terminal end of AphA (see Materials and Methods). In the presence of DTT, AphA was released from the
chitin-bound intein tag in highly purified form (greater than
98%). Comparison of the activity of AphA prepared by this
method and that described previously by both gel shift and
DNaseI footprinting (data not shown) indicated that their ability to bind to DNA was identical. As shown in Fig. 2B, chitinpurified AphA efficiently bound to a 135-bp tcpPH promoter
fragment derived from a wild-type classical biotype strain but
was unable to bind to similar fragments that contained one of
the nine substitution mutations identified above that reduced
transcription to less than 35%. In addition, the alteration at
position ⫺79, which decreased tcpPH expression to approximately 50%, also showed reduced AphA binding. However,
the changes at positions ⫺82 and ⫺80, which did not signifi-

cantly influence tcpPH expression, had no effect on AphA
binding. These results demonstrate that there is a complete
correlation between the influence of these various positions on
the expression of tcpPH and their ability to support AphA
binding. They also show that the sequence of the upstream
AphA recognition region (from ⫺95 to ⫺90) is more stringent
for AphA binding than that of the downstream region (⫺83 to
⫺78).
Identification of an AphA binding site upstream of a gene
encoding PVA. Determination of the base pairs critical for
AphA binding to the tcpPH promoter prompted us to investigate whether AphA might regulate other genes in V. cholerae
by using a similar binding site. To address this, we searched the
V. cholerae genome for the sequence TATGCA-N6-TNCNNA
in both the forward and reverse orientations by using
DNASTAR software and identified 11 additional sites on both
the large and small chromosomes that matched this consensus.
Of these sites, eight were located inside coding regions and
only one of the remaining three was capable of efficiently
binding AphA (see below). This site (TATGCA-N6-TACACA) was located on the small chromosome upstream of
gene VCA0877 that showed homology to the cholylglycine
hydrolase family of proteins. All of the base pairs shown above
to be important for AphA binding to the site in the tcpPH
promoter, including position ⫺79, which was intermediate in
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FIG. 3. Comparison of the AphA binding sites at the tcpPH and
pva promoters. Conserved positions are shown in bold.

phenotype, are completely conserved within this newly identified site (Fig. 3). In addition, the site displays better dyad
symmetry than the one at tcpPH, suggesting that AphA might
bind to it with even higher affinity.
The cholylglycine family of hydrolases comprise both conjugated bile salt hydrolases and PVAs, since they share extensive
sequence homology (5) and belong to the same group of Nterminal nucleophile hydrolases in which Cys-1 plays an essential role in the catalytic mechanism of the enzyme (42).
VCA0877 is predicted to encode a 38-kDa protein with approximately 26% identity to the conjugated bile salt hydrolase
from Clostridium perfringens (6) and 25% identity to PVA from
Bacillus sphaericus (37). By employing assays for both of these
activities we determined that the protein encoded by VCA0877
functions to hydrolyze penicillin V (see below), and we have
designated the gene pva. Unlike the enzymes from C. perfringens and B. sphaericus, both of which are intracellular, V. cholerae PVA is predicted to have a 31-amino-acid signal sequence
which directs it to the periplasm and which is cleaved to produce an N-terminal cysteine residue (34).
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AphA represses the expression of the pva gene in response to
cell density. To assess whether AphA regulates the expression
of the V. cholerae pva gene, a pva-lacZ fusion was constructed
in the chromosome of C6706 (strain GK925). As shown in Fig.
4A, the presence of a ⌬aphA mutation in GK925 increased
expression from the pva-lacZ fusion almost ninefold compared
to that of the wild-type fusion in AKI conditions at low cell
density. At high cell density, due to the fact that the expression
of the wild-type fusion itself increased approximately fourfold
compared to that at low cell density, the influence of the
⌬aphA mutation was somewhat less. These results showed that
pva expression is regulated both by AphA and cell density.
Since HapR has previously been shown to directly influence
the expression of aphA by binding to a recognition site in its
promoter (23), it seemed likely that the influence of cell density on the expression of pva was the result of changes in the
levels of AphA at different cell densities. To address this,
Western blots were performed with anti-AphA antibodies by
using extracts prepared from the strains shown in Fig. 4A, and
the results are shown in Fig. 4B. At low cell density (optical
density at 600 nm [OD600] ⫽ 0.2), the response regulator LuxO
indirectly represses the expression of hapR. Since HapR levels
are too low to strongly repress the expression of aphA under
this condition, AphA levels are high in C6706 and in the
wild-type pva-lacZ fusion strain GK925. This is consistent with
the low level of pva expression observed in strain GK925 at this
cell density (Fig. 4A). The presence of a ⌬hapR mutation in the
pva-lacZ fusion resulted in only a small increase in AphA levels
and a small reduction in pva expression, since hapR is largely

FIG. 4. Influence of ⌬aphA, ⌬hapR, and ⌬luxO mutations on a C6706 pva-lacZ fusion at low and high cell density. Strains were grown in AKI
conditions for 3.5 h (OD600 ⫽ 0.2) or for 7.5 h (OD600 ⫽ 4). (A) From left to right: GK925 (wild-type [wt] pva-lacZ); GK927 (⌬aphA); KSK1918
(⌬hapR); KSK1920 (⌬luxO). (B) Anti-AphA Western blot with strains grown as described for panel A. From left to right: C6706, GK925, GK927,
KSK1918, and KSK1920.
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FIG. 5. Nucleotide sequence of the proximal region of the pva promoter. The transcriptional start site (⫹1), ATG codon, and ⫺10 and ⫺35
regions are shown. Boxes show the region of dyad symmetry involved in AphA recognition, and thick lines show the base pairs that are protected
from DNaseI digestion by AphA.

repressed under this condition. However, the presence of a
⌬luxO mutation in the pva-lacZ fusion reduced the amount of
AphA nearly in half due to increased expression of hapR, and
coincident with this the expression of the pva-lacZ fusion doubled.
At high cell density (OD600 ⫽ 4) LuxO is no longer capable
of indirectly repressing the expression of hapR, and HapR in
turn represses the expression of aphA. As shown in Fig. 4B,
AphA levels were considerably lower in both C6706 and the
wild-type pva-lacZ fusion strain due to repression by HapR
under this condition, consistent with the fourfold increase in
pva expression observed relative to low cell density. A ⌬hapR
mutation significantly increased the levels of AphA protein in
the pva-lacZ fusion strain and concomitantly decreased the
expression of the fusion under this condition close to the levels
observed at low cell density. In contrast, the ⌬luxO mutation
had only a small influence on AphA levels and pva-lacZ expression at high cell density, since hapR is not strongly repressed under this condition. These results show that pva expression is repressed by AphA and, as a result, is regulated in
response to cell density.
The activity of PVA is increased in a ⌬aphA mutant strain.
Since AphA represses the expression of the pva gene, it was of
interest to determine whether the activity of PVA was also
increased in V. cholerae strains lacking AphA. The enzyme
PVA catalyzes the hydrolysis of penicillin V (phenoxymethlypenicillin) to 6-APA, and the resulting product can be measured spectrophotometrically by using a colorimetric assay (see
Materials and Methods). Cell extracts from C6706 produced
about 15 U of PVA activity/g when grown for 7 h at 37°C, and
this value increased approximately sevenfold in a ⌬aphA mutant, consistent with the increased transcription of pva observed in this background. C6706 containing a ⌬pva mutation,
strain GK930, produced no detectable PVA activity under
these conditions, but when the strain contained a plasmid,
pGKK268, in which the V. cholerae pva gene was placed under
the control of the tac promoter, PVA activity increased to 136
U/g in the absence of isopropyl-␤-D-thiogalactopyranoside
(IPTG) and to 1,883 U/g in the presence of 0.01 mM IPTG.
Increasing the IPTG concentration to 0.1 mM increased the
activity from pGKK268 even further (data not shown). These
results clearly show that PVA activity correlates with the level
of gene expression in the cell.
Identification of the transcriptional start of the pva promoter. To determine the transcriptional start for the pva promoter, the technique of 5⬘ RACE (9) was carried out with
wild-type C6706. A strong product corresponding to the size

expected for the transcriptional start of pva was observed.
Sequencing of this RACE product revealed that the start of the
pva promoter is an A located 182 bp upstream of the ATG
(Fig. 5). This positions the pva transcriptional start so as to lie
within the AphA binding site identified above and is consistent
with the role of AphA as a negative regulator at this promoter.
The ⫺10 sequence, TATAAA, has one mismatch from the
consensus TATAAT, whereas the ⫺35 sequence, TTGCGC, is
less well conserved, with three mismatches from the consensus
TTGACA.
AphA binds to and footprints the site in the pva promoter.
To assess whether AphA binds directly to the pva promoter, a
303-bp DNA fragment encompassing the region from ⫺113 to
⫹191 from the transcriptional start of the C6706 pva gene was
incubated with purified AphA. AphA efficiently shifted the
fragment, indicating that the protein is capable of binding
directly to the pva promoter (Fig. 6, lanes 2 and 3). On a
173-bp fragment extending from ⫹18 to ⫹191 that lacks the
AphA binding site, specific binding was lost (Fig. 6, lanes 5 and
6). When the 303-bp DNA fragment used above was amplified
from the classical biotype strain O395 and incubated with purified AphA, a shift identical to that of C6706 was observed
(Fig. 6, lanes 8 and 9). These results indicate that AphA binds
to the pva promoter from strains representative of both biotypes.
The ability of AphA to bind to the recognition sequence
overlapping the pva transcriptional start was confirmed by
DNaseI footprinting. As shown in Fig. 7A and B, on a 233-bp
fragment extending from ⫺113 to ⫹120, the AphA footprint
covers a region from approximately ⫺5 to ⫹21 on the top
strand and from approximately ⫺8 to ⫹20 on the bottom
strand. Thus, the footprint completely protects the identified
AphA binding site (see Fig. 5) and places AphA in a position
where it would likely interfere with transcription initiation.
The ⌬pva mutant does not influence virulence in V. cholerae.
Since AphA negatively regulates the pva gene while simultaneously activating tcpPH and the rest of the genes that comprise the virulence cascade, it might not be expected that pva
would have a role in virulence, since its expression is opposite
from that of the other virulence genes. To assess this, competition experiments in infant mice were carried out with the
C6706 ⌬pva mutant GK930 and the ⌬lac wild-type strain
KSK262. These experiments revealed no difference in the ability of these strains to colonize infant mouse intestines, suggesting that the product of the pva gene plays a role for V. cholerae
in a different biological niche, most likely under conditions in
which the ability of AphA to repress its promoter is reduced.
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FIG. 6. A. Binding of purified AphA to the pva promoter. Lanes 1 to 3, a 303-bp fragment amplified from C6076; lanes 4 to 6, a 173-bp fragment
amplified from C6706; lanes 7 to 9, the 303-bp fragment amplified from O395. The first lane in each set has no protein added, the second lane
has 5 ng (15 nM) of AphA, and the third lane has 50 ng (150 nM) of AphA. (B) Diagrammatic representation of the binding fragments used for
panel A. The gray box shows the AphA binding site.

DISCUSSION
AphA was initially identified as a chromosomally encoded
activator of the VPI tcpPH operon (41). Since the ability of
AphA to activate the expression of tcpPH appears to have been
acquired at a point in evolution subsequent to integration of
the VPI element into the large chromosome, it seemed likely
that AphA would have other regulatory roles in V. cholerae,
possibly coordinating the expression of those genes together
with or opposite from those with roles in virulence. We show
here that by determining the base pairs critical for AphA
binding and transcriptional activation at the tcpPH promoter,
we were able to identify a second binding site for AphA on the
small chromosome upstream of a gene encoding a PVA.
All of the base pairs in the tcpPH binding site that are
important for AphA binding (from ⫺95 to ⫺90 and ⫺83, ⫺81,
⫺79, and ⫺78) are conserved within the site upstream of the
pva gene. In fact, the pva binding site displays better dyad
symmetry than that at tcpPH, suggesting that AphA may bind
with even higher affinity to this site. A total of 11 other sites

were found in the V. cholerae genome that contained the base
pairs most important for AphA binding at tcpPH, and the
majority of these sites were found to lie within coding regions.
It is possible that AphA regulates other genes in V. cholerae by
recognizing binding sites that deviate from those at tcpPH and
pva, and this is presently under investigation. Although there
are two base pair differences, positions ⫺86 and ⫺87, in the
AphA binding site between the classical strain O395 and the El
Tor strain C6706, these changes lie between the regions of
dyad symmetry and do not influence AphA binding or transcriptional activation (20, 22). From the symmetry of the AphA
recognition sites at tcpPH and pva, it appears that AphA is
binding as a dimer. It is interesting that at tcpPH all of the
contacts in the upstream half site (from ⫺95 to ⫺90) are
essential for AphA binding and transcriptional activation,
whereas in the downstream half site (⫺83 to ⫺78) the most
important positions are those which maintain the symmetry
(⫺83, ⫺81, and ⫺78). Thus, the downstream half site appears
to be less stringent for AphA binding than the upstream half
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FIG. 7. DNaseI footprint for AphA at the pva promoter. (A) Top strand of a 233-bp fragment from ⫺113 to ⫹120. Lane 1, no protein; lane
2, 250 ng (2.5 M) of AphA; lane 3, 300 ng (3 M) of AphA. (B) Bottom strand of the 233-bp fragment. Lanes 1 to 3 are the same as those
described for panel A.

site. A variety of data suggested that at tcpPH, AphB plays an
active role in RNA polymerase recruitment, whereas AphA
plays an accessory role, possibly by altering the conformation
of the DNA to facilitate AphB binding (21). The finding that
one of the normal roles for AphA in V. cholerae is as a negative
regulator at pva further supports the notion that this protein
functions through steric mechanisms as opposed to direct interactions with RNA polymerase itself.
The location of the AphA binding site overlapping the pva
transcriptional start is consistent with its negative mode of
function at this promoter. It seems likely that by binding to this
site, AphA interferes with the ability of RNA polymerase to
access the promoter. It is interesting that the family of phenolic
acid decarboxylase regulators (PadR), of which AphA is a
member, appears to exhibit a similar mode of repression (1).
Inverted repeats which potentially serve as the target sites for
PadR binding are located in the vicinity of the transcriptional

start of the padA genes of Pediococcus pentosaceus, Lactobacillus plantarum, Bacillus subtilis, and Bacillus pumilus. Although V. cholerae appears to encode a phenolic acid decarboxylase (VC2240) that shows a high degree of homology to
those of P. pentosaceus (48%) and L. plantarum (47%), we
have not been able to show that AphA binds to the promoter
of this gene or significantly influences its expression (data not
shown). Thus, it does not appear that AphA regulates the
expression of the phenolic acid decarboxylase gene in V. cholerae.
The expression of aphA is controlled by quorum sensing
through the repressive action of HapR (23). By virtue of the
ability of AphA to activate the expression of tcpPH, this places
the rest of the virulence cascade also under quorum-sensing
control (47). Likewise, the ability of AphA to repress pva
expression also imparts quorum-sensing regulation on this
gene. In fact, VCA0877 was previously identified in a microar-
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FIG. 8. Contrasting pathways of gene expression regulated by AphA in response to cell density. At least three sensory circuits, CqsAS (System
1), LuxSPQ (System 2), and the unknown components of proposed System 3 function in parallel to control the activity of LuxO in response to the
presence of autoinducers. At low cell density, activated LuxO indirectly represses the expression of hapR. The resulting high levels of AphA repress
the expression of pva and, in the presence of AphB, activate tcpPH expression and the rest of the virulence cascade. At high cell density, inactive
LuxO no longer represses hapR expression. HapR then reduces AphA levels by repressing expression from the aphA promoter. This derepresses
pva expression while simultaneously preventing the activation of tcpPH and the rest of the virulence cascade.

ray screen as a gene upregulated in a luxO mutant (47). Based
on the work presented here it is now known that this is an
indirect effect due to the repressive action of HapR on aphA
expression. At low cell densities, the response regulator LuxO
is phosphorylated by a relay from at least three quorum-sensing systems (30). According to the present model (Fig. 8 and
references 23, 30, and 47), under this condition LuxO activates
the expression of a putative repressor which decreases the
expression of hapR, thereby preventing HapR from binding to
the aphA promoter and repressing its expression. As confirmed
here by Western analysis, AphA levels are high in wild-type
C6706 under this condition, and the expression of the pva gene
is maximally repressed. In contrast, at high cell densities LuxO
is no longer able to activate the putative hapR repressor, and
HapR in turn represses the expression of aphA. Under this
condition AphA levels are reduced considerably and the expression of pva is increased. That pva expression increases even
further in the ⌬aphA mutant indicates that some repression by
AphA still occurs even at high cell density. Whether there are
other conditions that allow full derepression of pva expression
is not yet known and is presently under investigation.
AphA also regulates the expression of pva in the classical
biotype strain O395. The DNA sequence of the pva gene and
its promoter was found to be identical between O395 and
C6706, and AphA shifted the pva promoter in a similar manner
in both biotypes. In addition, an O395 pva-lacZ fusion was
found to be repressed by AphA between 14- and 17-fold at
both low and high cell densities (data not shown). Since O395
does not have a functional quorum-sensing system due to the
presence of a hapR frameshift mutation and a point mutation
in the aphA promoter that renders HapR incapable of binding
(23), the levels of AphA do not change in response to cell
density as in the C6706 strain background (data not shown).
This finding confirms that the presence of a functional quorum
sensing system is necessary for the derepression of pva expression that is observed in C6706 at high cell density.
Two different types of penicillin amidases, V and G, have

been identified in a wide variety of microorganisms and are
responsible for virtually all of the industrial production of
6-aminopenicillinic acid, the ␤-lactam precursor used for the
synthesis of penicillins with a wide range of antimicrobial activities. These amidases have distinct substrate preferences,
with PVA being active on phenoxyacetylated derivatives, such
as penicillin V, and penicillin G amidase (PGA) being active
on phenylacetylated derivatives, such as penicillin G. Although
the two enzymes have no detectable sequence homology, common structural patterns have been identified between them by
X-ray crystallography (42). PVA from B. sphaericus is a tetrameric enzyme consisting of four identical subunits with a
monomer molecular size of 35 kDa (36). The PVA from V.
cholerae shows 25% identity to the B. sphaericus enzyme and
has a predicted monomer molecular size of 38 kDa. One obvious difference between the two proteins is that the V. cholerae enzyme has a 31-amino-acid leader sequence (34) which
most likely directs it to the periplasm.
The activity of PGA from E. coli is controlled by a variety of
mechanisms, such as catabolite repression, induction by phenylacetic acid, and thermoregulation (44). Although less information is available regarding the regulation of PVA enzymes,
it has been reported for some organisms that expression is
similarly repressed by sugars and is induced by phenoxyacetic
acid (38). It is not yet known whether the V. cholerae pva gene
is regulated by catabolite repression, but pva expression did not
appear to be induced at low cell densities in AKI medium by
addition of phenoxyacetic acid, and the enzyme was found to
be active from cultures grown at both 30 and 37°C. In addition,
this is the first report of penicillin amidase activity being regulated by quorum sensing. Thus, there appears to be considerable variation in the mechanisms that are involved in the
regulation of penicillin amidases.
Although penicillin amidases are produced by a wide range
of microorganisms, their physiological role is still somewhat
unclear. The finding that these enzymes are capable of cleaving
other phenyl and phenoxyacetic acid derivatives in addition to
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penicillins, coupled with the regulatory mechanisms that involve induction and repression by different carbon sources,
suggests that penicillin amidases are involved in the assimilation of phenyl and phenoxyacetylated compounds in the environment (27, 44). These compounds, such as phenolic and
caffeic acids and flavonoids, are abundant in the environment
since they are produced by the degradation of plant cell material by microorganisms. Since E. coli PGA is active at 30°C or
lower, it has been suggested that temperature serves as a cue
for the expression of this gene in the environment where it
could function in scavenging phenylacetylated compounds. Although the V. cholerae enzyme is active at both 30° and 37°C,
a similar role for this enzyme might exist in the nonparasitic
environment. The finding that AphA regulates the expression
of pva opposite from those genes involved in virulence (see Fig.
8) supports this hypothesis.
Quorum sensing has been found to control a wide variety of
different physiological activities in both gram-positive and
gram-negative bacteria, such as bioluminescence, biofilm formation, virulence, sporulation, conjugation, and antibiotic production (29). Regulation of penicillin amidase activity can now
be added to this growing list of activities controlled by quorum
sensing. Regulating PVA expression by quorum sensing may
allow V. cholerae to gain access to additional nutrient sources
once the cells have achieved a certain cell density in a particular niche and the preferred substrates have been utilized.
Although it is not yet known whether pva expression can be
induced by other conditions in strains that have a hapR frameshift mutation or a point mutation in the aphA promoter that
prevents HapR from repressing its expression, it appears that
these strains might be at a disadvantage in certain environments relative to strains with a functional quorum-sensing system.
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